Aristotelian University of Thessaloniki
Findings from Greece, the South Korea and Italy advance knowledge in diabetes research
Published in Biotech Law Weekly, May 5th, 2006
Study 1: Early quinapril or losartan improved both diabetic autonomic neuropathy and left ventricular diastolic dysfunction in asymptomatic patients with type 1 or 2 diabetes mellitus, after 1 year of treatment.
In a recently published article, scientists in Greece conducted a study "to investigate the effect of angiotensin converting enzyme inhibition (ACE-I) or angiotensin receptor blockade (ARB), and their combination, on both diabetic autonomic neuropathy (DAN) and left ventricular (LV) diastolic dysfunction (LVDD) in asymptomatic patients with diabetes mellitus...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Law Weekly
Source: Biotech Law Weekly (2006-05-05)
More Articles from Biotech Law Weekly
- Bioniche Life Sciences, Inc.
Bioniche receives U.S. FDA approval to proceed with phase III bladder cancer trials - Cobalis Corp.
Cobalis settles outstanding litigation with Gryphon Master Fund, L.P. - Hospice
VITAS hospice secures state license, Medicare certification for north Virginia opening - Market Analysis
Report suggests only 20% of seniors expect to enroll in a prescription drug plan - Medicare
AHIP member plans work with AMA, beneficiary groups to simplify Medicare Part D administration - Medicare
Progress report shows many seniors are choosing alternatives to the standard Medicare drug plan - More from this issue of Biotech Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
